Less than 50% of employers cover GLP-1 drugs for weight loss: JPM survey
JPMorgan's annual survey of 40 executives shows that coverage of popular weight-loss drugs continues to slowly increase annually but still remains low compared to the coverage of the same drugs for ...
NBC Los Angeles1h
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, CMS says
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...
As demand for weight-loss drugs rises, states grapple with Medicaid coverage
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...
gastroenterologyadvisor7h
FDA Approves Zepbound for Sleep Apnea in Patients With Obesity
The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.
Apple Fitness+ adds new programs to boost your physical and mental health in 2025
Are you looking to take your health to another level in 2025? Learn everything you need to know about Apple Fitness+ new ...
healthday10h
Some GLP-1s Achieve More Weight Loss Than Others: Study
Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...